Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: The real concerns should be....

Thank you for your input, it is truly appreciated.

I understand the concern you voice but I'm relying on what the BoD/Gloria advised as to their future intent. If they deviate from that intent, they should expect a shareholder reaction (revolt).

As for the Examiner/USPTO, IMO they are already ripe for a tar and feather. IMO (and that of Henneman I believe) they should never have initiated/approved this latest re-exam to begin with. There should have been some in-house review of the re-exam then in process, as well as the basis for that prior re-exam, before making the decision to proceed. All water under the bridge at this point, though IMO the USPTO cannot hide from some level of embarrassment. I'm just a little shocked that the Examiner has taken no visible action, especially after the 3/2/10 input from Henneman.

Thank you again,

SGE

PS: Tar and feather. Originally, the idea with this practice was to tar, feather, and ignite - causing a miserable death. Later the practice was more a threat. Tar, feather, and march the recipient around town with the threat that someone he had wronged would light a match. It seems it would have been effective!

Share
New Message
Please login to post a reply